Literature DB >> 21515792

Runx3 is required for full activation of regulatory T cells to prevent colitis-associated tumor formation.

Manabu Sugai1, Koji Aoki, Motomi Osato, Yukiko Nambu, Kosei Ito, Makoto M Taketo, Akira Shimizu.   

Abstract

Inflammation is increasingly recognized as an essential component of tumorigenesis, which is promoted and suppressed by various T cell subsets acting in different ways. It was shown previously in Runx3-deficient mice that differentiation of CD8 T and NK cells is perturbed. In this study, we show that Runx3 is also required for proper differentiation and function of regulatory T cells. In Runx3-deficient mice, T cells were unable to inhibit inflammation and to suppress tumor development. As expected, recombination activating gene 2-deficient mice bearing Runx3-deficient lymphocytes spontaneously developed colon tumors. However, tumor formation was completely blocked by transfer of either regulatory T cells or CD8 T cells derived from wild-type mice to mutant mice or by housing mutant mice in a specific pathogen-free condition. These results indicate that Runx3-deficient lymphocytes and microorganisms act together to induce inflammation and consequently induce the development of colon tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515792     DOI: 10.4049/jimmunol.1001671

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.

Authors:  Payal Mittal; Rebecca Abblett; Joseph M Ryan; Adam T Hagymasi; Archibald Agyekum-Yamoah; Julia Svedova; Steven L Reiner; Marie-Clare St Rose; Matthew P Hanley; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2018-01-05       Impact factor: 5.422

2.  Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.

Authors:  Remond J A Fijneman; Rebecca A Anderson; Ethan Richards; Jieming Liu; Marianne Tijssen; Gerrit A Meijer; Janae Anderson; Annette Rod; Michael G O'Sullivan; Patricia M Scott; Robert T Cormier
Journal:  Cancer Sci       Date:  2012-01-19       Impact factor: 6.716

Review 3.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

Review 4.  Regulatory T cells in inflammatory bowel diseases and colorectal cancer.

Authors:  Györgyi Műzes; Béla Molnár; Ferenc Sipos
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

5.  Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer.

Authors:  B Kurklu; R H Whitehead; E K Ong; T Minamoto; J G Fox; J R Mann; L M Judd; A S Giraud; T R Menheniott
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

6.  Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells.

Authors:  Andreas Kyburz; Angela Fallegger; Xiaozhou Zhang; Aleksandra Altobelli; Mariela Artola-Boran; Timothy Borbet; Sabine Urban; Petra Paul; Christian Münz; Stefan Floess; Jochen Huehn; Timothy L Cover; Martin J Blaser; Christian Taube; Anne Müller
Journal:  J Allergy Clin Immunol       Date:  2018-09-19       Impact factor: 10.793

Review 7.  From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs?

Authors:  Mostafa Vaghari-Tabari; Niloufar Targhazeh; Soheila Moein; Durdi Qujeq; Forough Alemi; Maryam Majidina; Simin Younesi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-04-11       Impact factor: 5.722

8.  Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer.

Authors:  Rui-jing Tang; Su-nan Shen; Xiao-yin Zhao; Yun-zhong Nie; Yu-jun Xu; Jing Ren; Ming-ming Lv; Ya-yi Hou; Ting-ting Wang
Journal:  Stem Cell Res Ther       Date:  2015-04-13       Impact factor: 6.832

9.  In situ differentiation of CD8αα Τ cells from CD4 T cells in peripheral lymphoid tissues.

Authors:  Yukiko Nambu; Tatsunari Hayashi; Kyoung-Jin Jang; Koji Aoki; Hiroto Mano; Keiko Nakano; Motomi Osato; Katsu Takahashi; Katsuhiko Itoh; Satoshi Teramukai; Toshihisa Komori; Jun Fujita; Yoshiaki Ito; Akira Shimizu; Manabu Sugai
Journal:  Sci Rep       Date:  2012-09-07       Impact factor: 4.379

Review 10.  The dual role of inflammation in colon carcinogenesis.

Authors:  Giovanni Monteleone; Francesco Pallone; Carmine Stolfi
Journal:  Int J Mol Sci       Date:  2012-09-06       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.